Skip to main content

Home/ Cancer/ Group items tagged disease

Rss Feed Group items tagged

Matti Narkia

Vitamin D levels associated with survival in lymphoma patients - 0 views

  •  
    ScienceDaily (Dec. 5, 2009) - A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival. The results will be presented at the annual meeting of the American Society of Hematology in New Orleans.

    Also, several recent reports have concluded that vitamin D deficiency is associated with poor outcomes in other cancers, including breast, colon and head and neck cancer. This is the first study to look at lymphoma outcome.
Matti Narkia

Welcome to to VITamin D and omegA-3 triaL (VITAL) Web site - 0 views

  •  
    What is VITAL?

    The VITamin D and OmegA-3 TriaL (VITAL) is a research study in 20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin D (about 2000 IU) or fish oil (about 1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. Recruitment for the study will begin in January 2010.
Matti Narkia

Cancer - 0 views

  •  
    nightsurfer's cancer related Diigo list
Matti Narkia

Sphingolipids in food and the emerging importance of sphingolipids to nutrition. - J Nu... - 0 views

  •  
    Sphingolipids in food and the emerging importance of sphingolipids to nutrition.
    Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr.
    J Nutr. 1999 Jul;129(7):1239-50. Review.
    PMID: 10395583
Matti Narkia

Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's ... - 0 views

  •  
    Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease -- Brewer 226 (7): 665 -- Experimental Biology and Medicine
1 - 5 of 5
Showing 20 items per page